Moderna Inc
Pfizer swings to quarterly loss due to Paxlovid, Covid vaccine write-offs
CFOTO | Future Publishing | Getty Images Pfizer on Tuesday reported a narrower than expected loss for the third quarter as the drugmaker recorded charges largely related to struggles for its Covid antiviral treatment Paxlovid and Covid vaccine. Pfizer said that it recorded a $5.6 billion charge for inventory write-offs in the third quarter due […]
Read More
Jamie Dimon’s stock-moving trades show why investors should track CEOs’ buying and selling
For the first time in nearly two decades running JPMorgan Chase, CEO Jamie Dimon will voluntarily sell stock in the bank. The disclosure, in a securities filing Friday, detailed next year’s planned sales — pressuring JPMorgan (JPM) shares and the Dow Jones Industrial Average and highlighting why tracking trades made by executives involving the companies […]
Read More
These shares reporting upcoming week ordinarily defeat the Road and rally
Wall Road is bracing for a further chaotic 7 days of earnings as the reporting time period reaches its midway place — and specific shares are most likely to carry out better on the back again of their experiences. Roughly 29% of the S & P 500 is set to report up coming 7 days. […]
Read More
Below are the most oversold stocks due for a bounce adhering to the market’s challenging week
This week’s significant industry market-off could bode nicely for particular shares, including Tesla and Moderna , based mostly on one well-known metric. Investors are reeling from a challenging session Thursday, with the S & P 500 and tech-heavy Nasdaq Composite dropping more than 1% just about every through the day’s buying and selling session, and […]
Read More
Pfizer’s combination Covid, flu vaccine will move to final-stage trial after positive data
CFOTO | Future Publishing | Getty Images Pfizer on Thursday said its combination vaccine candidates targeting Covid and the flu will move to a final-stage trial in the coming months after showing positive initial results in an early to mid-stage study. That moves the pharmaceutical giant and its German partner BioNTech one step closer to […]
Read More
Bristol Myers Squibb earnings top estimates even as top-selling drug fights generic competition
Bristol Myers Squibb on Thursday reported quarterly adjusted earnings that topped expectations and posted revenue in line with estimates, even as sales of the company’s popular blood cancer drug Revlimid plummeted due to generic competition. Bristol Myers, one of the world’s largest pharmaceutical companies, raked in $10.96 billion in revenue for the third quarter, down […]
Read More
Merck results beat expectations on strong Keytruda sales, surprise Covid drug growth
Merck headquarters in Rahway, New Jersey, on Tuesday, April 18, 2023. Christopher Occhicone | Bloomberg | Getty Images Merck on Thursday reported third-quarter revenue and adjusted earnings that topped expectations on strong sales of its blockbuster cancer drug Keytruda, HPV vaccine Gardasil and surprisingly, its Covid drug Lagevrio. The pharmaceutical giant also increased its full-year […]
Read More
Stocks creating the greatest moves midday: Lululemon, Pfizer, News Corp, Charles Schwab and extra
Examine out the businesses producing the greatest moves midday. Lululemon — Shares of the athleisure apparel business surged much more than 10% right after S & P Dow Jones Indices declared that the firm’s stock will be included to the S & P 500 on Wednesday. Lululemon will replace Activision Blizzard following the completion of […]
Read More
Novavax’s updated Covid vaccine can still catch up to Pfizer, Moderna shots this fall
A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands. Patrick Van Katwijk | Getty Images Americans can finally get their hands on Novavax‘s newest Covid vaccine after U.S. regulators greenlighted the shot this week. […]
Read More
Moderna combination Covid, flu vaccine moves to final stage trial after positive data
Artur Widak | Nurphoto | Getty Images Moderna on Wednesday said its combination vaccine targeting Covid and the flu will move to a final stage trial in adults ages 50 and above this year after showing positive results in an early to mid-stage study. The biotech company hopes its shot, mRNA-1083, can win approval from […]
Read More